Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Mutlu Demiray

9PUBLICATIONS

8CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyMedical mycologyHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Feb 06, 2025

Precision-Guided Durable Response From Venetoclax With Decitabine in a Patient With a Metastatic Refractory <i>IDH2</i>-Mutant Cholangiocarcinoma.

Eylül Özgü, Ünal Metin Tokat, Ashkan Adibi

|Nov 14, 2024

Elacestrant plus alpelisib in an <i>ESR1</i> and <i>PIK3CA</i> co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety.

Ünal Metin Tokat, Şevval Nur Bilgiç, Esranur Aydın

|Oct 25, 2024

Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers.

Ünal Metin Tokat, Ashkan Adibi, Esranur Aydın

|Apr 22, 2024

Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations.

Esranur Aydın, Ünal Metin Tokat, Eylül Özgü

|Dec 21, 2023

Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.

Eylül Özgü, Esranur Aydin, Ashkan Adibi

|Dec 18, 2023

PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview.

Ashkan Adibi, Ünal Metin Tokat, Eylül Özgü

Pageof 2

Frequent Collaborators

6 joint publications

Esranur Aydın

5 joint publications

Ashkan Adibi

5 joint publications

Eylül Özgü

4 joint publications

Ünal Metin Tokat

3 joint publications

Şevval Nur Bilgiç

1 joint publications

Jiancheng Hu

1 joint publications

Irem Demiray

1 joint publications

Razelle Kurzrock

Frequent Collaborators

6 joint publications

Esranur Aydın

5 joint publications

Ashkan Adibi

5 joint publications

Eylül Özgü

4 joint publications

Ünal Metin Tokat

Top Related Videos

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on : Dec 02, 2013

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

See more related videos

Top Related Videos

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on : Dec 02, 2013

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

See more related videos